Based on prior knowledge, we know that fibrinolytic therapy is a treatment used in the management of acute myocardial infarction. In this case, the feature "fibr_ter_01" represents whether the patient received fibrinolytic therapy using the drug Celasim 750k IU. 

To analyze the relationship between the feature "fibr_ter_01" and the presence of chronic heart failure in the myocardial infarction complications data, we need to examine the distribution of "fibr_ter_01" values for each target class (no, yes).

Here is a dictionary that describes the relationship between "fibr_ter_01" and chronic heart failure:

```json
{
    "no": ["no"],
    "yes": ["yes"]
}
```

Explanation:
- For the "no" class (patients without chronic heart failure), the possible value of "fibr_ter_01" is "no".
- For the "yes" class (patients with chronic heart failure), the possible value of "fibr_ter_01" is "yes".

Based on this analysis, we can conclude that the presence of chronic heart failure is independent of the fibrinolytic therapy administered with Celasim 750k IU.